RE: Placing23 Feb 2024 07:18
Sales have always been made per accounts, CPT code will make it easier and more wide reaching, IB llc, American arm which Mike & Cath work for are profitable, they receive all the grant income and sales, IQAI is loss making due to directors salaries of £160k, auditors remuneration £34k, amortisation of £134k, CLN loan interest £10k and stock exchange listing expenses, RNSs are £4k ago apparently and finally research cost of £166k for Glm, make up the £511k loss, all per the December 2022 accounts, Trevor choose the cheap placing , still eating on RNSs re who took the £20mill at 1.5p, can’t believe they have all been pre sold, not enough volume, have a good day everyone!